They also confirmed a positive correlation between mediators of inflammation (i.e., IL-16, PI3/elafin, E-selectin, CCL7) and AD disease severity, but not with BMI, pointing out the influence of AD on cardiometabolic risk independently of BMI [27]. The gene discussed is IL16; the disease is Alzheimer disease.